Using a Dye to Guide Brain Tumor Surgery
Part of Brain & nervous system, Cancer clinical trials.
This study tests whether a special dye called 5-ALA can help surgeons see tumor tissue more clearly during brain tumor surgery. If you are having surgery for a high-grade glioma or another brain tumor, you may be able to join and help improve surgical precision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are scheduled for surgery to remove a brain tumor that is suspected to be a high-grade glioma (grade 3 or 4) or another type of brain tumor.
- You are able to give your informed consent to join the study.
- You are not in a vulnerable group such as children, pregnant women, prisoners, or those with intellectual disabilities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called 5-ALA (which helps surgeons see tumor cells more clearly during surgery) is safe and effective in children with certain brain tumors. It is given as a liquid before surgery, and the goal is to help the surgeon remove more of the tumor while protecting healthy brain tissue.
This trial compares two surgical techniques for removing malignant brain tumors: one using a special dye (5-ALA) that makes tumor cells glow under a blue light, versus the standard white light surgery. The goal is to see if the dye-guided approach helps surgeons remove more of the tumor safely.
This trial tests a drug called 5-ALA that makes brain tumor cells glow under a special light during surgery. This helps surgeons see and remove more of the tumor safely, potentially improving outcomes for children with high-grade brain tumors.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This study looks at how your immune system reacts to brain tumor surgery and standard treatment, using a special dye to help the surgeon see the tumor better. It aims to find out if this approach can improve outcomes for people with glioblastoma.
This study tests a special imaging device (GLOW400) used during brain surgery for high-grade glioma. The device works with a fluorescent dye (5-ALA) to help the surgeon see the tumor more clearly, which may improve removal of the tumor while protecting healthy brain tissue.
Hear when a new Brain Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.